A practical reference on GRF(1-29): what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-10-16 and is reviewed periodically as new material appears.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
| Property | Value | Notes |
|---|---|---|
| Molecular weight (no linker) | ~3.37 kDa | Calculated from peptide sequence |
| Molecular weight (with linker) | ~3.65 kDa | Includes albumin-binding moiety |
| Appearance | White to off-white powder | Typically lyophilized |
| Solubility | Soluble in water | Also dissolves in aqueous buffers |
| Common synonyms | Modified GRF(1-29), DAC:GRF | Usage varies by source |
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
=== Telemedicine integration === The rapid expansion of telemedicine during COVID-19 created natural synergies with DTC testing, enabling remote consultation for test result interpretation and follow-up care.
== Applications == The Schotten–Baumann reaction is widely used in organic chemistry. The industrial synthesis of flutamide, a nonsteroidal antiandrogen pharmaceutical drug, serves as a good example. In the Fischer peptide synthesis (Emil Fischer, 1903), an α-chloro acid chloride is condensed with the ester of an amino acid. The ester is then hydrolyzed and the acid converted to the acid chloride, enabling the extension of the peptide chain by another unit. In a final step the chloride atom is replaced by an amino group, completing the peptide synthesis.
The Kawakawa (Piper excelsum) plant, known also as "Māori kava", may be confused with kava. While the two plants look similar and have similar names, they are different, but related, species. Kawakawa is a small tree endemic to New Zealand, having importance to traditional medicine and Māori culture. As noted by the Kava Society of New Zealand, "in all likelihood, the kava plant was known to the first settlers of Aotearoa [New Zealand]. It is also possible that (just like the Polynesian migrants that settled in Hawaii) the Maori explorers brought some kava with them. Unfortunately, most of New Zealand is simply too cold for growing kava and hence the Maori settlers lost their connection to the sacred plant." Further, "in New Zealand, where the climate is too cold for kava, the Maori gave the name kawa-kawa to another Piperaceae M. excelsum, in memory of the kava plants they undoubtedly brought with them and unsuccessfully attempted to cultivate. The Maori word kawa also means "ceremonial protocol", recalling the stylized consumption of the drug typical of Polynesian societies". Kawakawa is commonly used in Maori traditional medicine for the treatment of skin infections, wounds, and cuts, and (when prepared as a tea) for stomach upsets and other minor illnesses.
Every 50th time the Apple II program was run, it would display a poem titled "Elk Cloner: The Program with a Personality", with the verse, "It will get on all your disks/ It will infiltrate your chips/ Yes it's Cloner/ It will stick to you like glue /It will modify RAM too/ Send in the Cloner!" Born: Lee Seung-gun, South Korean dentist and businessman who became a billionaire after his founding of the financial services company Viva Republica in 2014; in Seoul Died: Stanley Holloway, 91, English stage and film actor known for portraying Eliza Doolittle's father in My Fair Lady onf film and stage Lluís Nonell, 55, Spanish stage, film and TV actor, died on stage at the Teatro Princesa in Valencia while performing in the play El diluvio que viene, during "a scene in which he addressed the audience, prentending to throw them coins." Helen Merrell Lynd, 85, American sociologist and co-author, with her husband Robert S. Lynd, of Middletown: A Study in Modern American Culture, the detailed 1929 study of a small American municipality, later revealed to have been Muncie, Indiana Refaat Al-Gammal, 54, Egyptian spy and agent for the Mukhabarat, Egypt's intelligence agent and secret police, died of lung cancer in Götzenhain in West Germany, where he had lived under the alias "Jacques Bitton". Samuel "Lightnin'" Hopkins, 69, African-American country blues singer and guitarist Virginia Marshall, 63, American child actress in silent film, including the Tom Mix western My Own Pal (1926)
Sources: en.wikipedia.org
== Utility in prediction == The utility of the criteria in determining the prognosis of patients with acute liver failure is defined by their operating characteristics. The positive predictive value of the criteria in predicting death from acute liver failure has ranged from 70% to 100%. A Canadian meta-analysis assessing various prognostic indices found that the specificity of the King's College criteria in predicting mortality exceeded 90%, with a sensitivity of 69%. As a result, the American Society for Study of Liver Diseases has recommended the King's College Criteria as being helpful early parameters in ascertaining the need for liver transplantation in patients with acute liver failure.
The parenteral route is any route that is not enteral (par- + enteral). Parenteral administration can be performed by injection, that is, using a needle (usually a hypodermic needle) and a syringe, or by the insertion of an indwelling catheter. Locations of application of parenteral administration include:
== Education == Cooks received Bachelor of Science and Master of Science degrees from the University of Natal in South Africa in 1961 and 1963, respectively. He received a Ph.D. from the University of Natal in 1965 and a second Ph.D. from Cambridge University in 1967, where he worked with Peter Sykes. He then did post-doctoral work at Cambridge with Dudley Williams.
== Pharmacokinetics == Valsartan has an oral bioavailability of approximately 25% and reaches peak blood concentrations around 2–4 hours after ingestion. The estimated elimination half-life is determined to be approximately 6 hours, volume distribution of 17 litres, and a protein binding of 95% is seen. The elderly may see increases in half life of the drug by up to 35% but dosing adjustment will not typically be warranted, however the drug should be used with caution in severe liver or kidney impairment. Majority of the drug is eliminated through the feces (83%) while only a small portion is eliminated in the urine (13%). Most of the drug excreted is unchanged, only small portion of the drug is metabolized to its inactive form 4-hydroxyvaleryl valsartan, the enzyme suspected to be responsible for this is the liver enzyme CYP2C9. Hydrochlorothiazide has an oral bioavailability of 70% and reaches peak concentration around 1.5–2 hours following ingestion. The half-life is quite variable for this drug and can range from 5–15 hours. This drug is not metabolized and is mostly excreted unchanged in the urine (60-70%). Protein binding ranges between 40 and 70% and volume of distribution varies from 4-8L/kg.
In the same way that diatoms can regulate the fatty acid composition within their plastid membranes, they can also regulate the plasma membranes surrounding each cell. As temperatures decrease, membranes become less fluid. Both bacteria and sea ice diatoms can alter the fatty acid composition within their membranes to include more unsaturated fatty acids, which allow the plasma membrane to maintain fluidity in extreme cold temperatures.
Sources: en.wikipedia.org
=== Supercritical fluid in power generation === The efficiency of a heat engine is ultimately dependent on the temperature difference between heat source and sink (Carnot cycle). To improve efficiency of power stations the operating temperature must be raised. Using water as the working fluid, this takes it into supercritical conditions. Efficiencies can be raised from about 39% for subcritical operation to about 45% using current technology. Many coal-fired supercritical steam generators are operational all over the world. Supercritical carbon dioxide is also proposed as a working fluid, which would have the advantage of lower critical pressure than water, but issues with corrosion are not yet fully solved. One proposed application is the Allam cycle. Supercritical water reactors (SCWRs) are proposed advanced nuclear systems that offer similar thermal efficiency gains.
=== European Union === The European Union defines a VOC as "any organic compound as well as the fraction of creosote, having at 293.15 K a vapour pressure of 0.01 kPa or more, or having a corresponding volatility under the particular conditions of use;". The VOC Solvents Emissions Directive was the main policy instrument for the reduction of industrial emissions of volatile organic compounds (VOCs) in the European Union. It covers a wide range of solvent-using activities, e.g. printing, surface cleaning, vehicle coating, dry cleaning and manufacture of footwear and pharmaceutical products. The VOC Solvents Emissions Directive requires installations in which such activities are applied to comply either with the emission limit values set out in the Directive or with the requirements of the so-called reduction scheme. Article 13 of The Paints Directive, approved in 2004, amended the original VOC Solvents Emissions Directive and limits the use of organic solvents in decorative paints and varnishes and in vehicle finishing products. The Paints Directive sets out maximum VOC content limit values for paints and varnishes in certain applications. The Solvents Emissions Directive was replaced by the Industrial Emissions Directive from 2013.
Materials science evolved, starting from the 1950s because it was recognized that to create, discover and design new materials, one had to approach it in a unified manner. Thus, materials science and engineering emerged in many ways: renaming and/or combining existing metallurgy and ceramics engineering departments; splitting from existing solid state physics research (itself growing into condensed matter physics); pulling in relatively new polymer engineering and polymer science; recombining from the previous, as well as chemistry, chemical engineering, mechanical engineering, and electrical engineering; and more. The field of materials science and engineering is important both from a scientific perspective, as well as for applications field. Materials are of the utmost importance for engineers (or other applied fields) because usage of the appropriate materials is crucial when designing systems. As a result, materials science is an increasingly important part of an engineer's education. Materials physics is the use of physics to describe the physical properties of materials. It is a synthesis of physical sciences such as chemistry, solid mechanics, solid state physics, and materials science. Materials physics is considered a subset of condensed matter physics and applies fundamental condensed matter concepts to complex multiphase media, including materials of technological interest.
The dressing is applied to a cleaned wound, and usually used to treat uninfected wounds. The dressings may be used, under medical supervision and with an antibiotic to treat the infection, even where aerobic bacterial infection is present. In addition to treating abrasions, minor incisions and lacerations, and superficial puncture wounds, hydrocolloid dressings are used to cover skin-graft donor sites, burns, and cutaneous ulcers (including pressure ulcers or "bed sores", venous ulcers, and diabetic foot ulcers). Small hydrocolloid patches are sometimes also used for acne, to heal the pimples and avoid scars from them. Large dressings with a consistent, adhesive film across the active side (rather than a central pad of hydrocolloid foam) can be cut into smaller strips or other shapes, for use in place of a traditional adhesive bandage of the same size. An indirectly medical use of strips of hydrocolloid dressing is as an alternative to surgical tape, e.g. to secure a nasogastric tube or CPAP mask to a patient's face.
Sources: en.wikipedia.org
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.
Early development used the albumin-binding form, and a shorter variant was later discussed under the same label. Because the two differ in half-life and handling, ambiguity arises whenever a source omits the variant designation.
The compound derives from that fragment but is not identical to it. The parent fragment lacks the stabilizing substitutions, so its degradation rate and duration of action differ noticeably.
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.